Durgical
EN
Open the app

Treating inborn errors of immunity: IgG, transplant, gene therapy

  • Topic

Children born with immune defects can be protected with antibiotics and antibody replacement, and many can be cured with a stem cell transplant or gene therapy.

Updated

What it is

Treatment of inborn errors of immunity follows the defect. All patients need infection prevention and careful vaccination; antibody defects are treated with lifelong IgG replacement; severe T-cell and some phagocyte or regulatory defects are cured by haematopoietic stem cell transplant; gene therapy and enzyme replacement are options for specific diseases; and targeted drugs now correct some dysregulation disorders. Early diagnosis, including newborn screening for SCID, greatly improves results.

Key facts

  • BCG is especially dangerous in SCID and should not be given until SCID is excluded where screening exists.
  • Gene therapy uses the patient’s own stem cells corrected with a viral vector; it avoids GVHD but carries a risk of insertional mutagenesis with older vectors.
  • Patients with IgA deficiency and anti-IgA antibodies can react to blood products.

Step by step

  1. Newborn screening measures TRECs in a dried blood spot; very low TRECs suggest SCID.
  2. The infant is protected from infection, given PJP prophylaxis and IgG, and no live vaccines (BCG, rotavirus).
  3. Only irradiated, leukoreduced, CMV-safe blood is given, to prevent transfusion-associated GVHD.
  4. A donor is sought: matched sibling first, then matched unrelated, haploidentical or cord blood.
  5. Transplant (or gene therapy for some types) restores T cells, best before infections, in the first months of life.
  6. B-cell function may not recover fully, so some patients stay on IgG replacement.

Treatment by type of defect

DefectMain treatmentsExamples
Antibody deficiencyIgG replacement (intravenous or subcutaneous), antibiotics, avoid live vaccines in severe formsXLA, CVID, hyper-IgM
Severe combined immunodeficiencyIsolation from infection, PJP prophylaxis, IgG, irradiated CMV-safe blood, then stem cell transplantX-SCID, ADA-SCID, RAG deficiency
ADA deficiencyEnzyme replacement as a bridge; transplant or gene therapyADA-SCID
Phagocyte defectsAntibacterial and antifungal prophylaxis, IFN-γ in CGD; stem cell transplantChronic granulomatous disease, leukocyte adhesion deficiency
Complete athymiaCultured thymus tissue implantationComplete DiGeorge syndrome
Immune dysregulationTargeted drugs, transplantAbatacept for CTLA-4/LRBA; JAK inhibitors for STAT gain of function; HLH regimens
Complement defectsVaccination (meningococcal, pneumococcal), prophylaxis; C1-inhibitor therapy in hereditary angioedemaTerminal complement deficiency, HAE

Common traps

  • IgG replacement fixes any immunodeficiency: it replaces antibody only, and does not correct T-cell, phagocyte or complement defects.
  • BCG at birth is harmless for every infant: in SCID it can cause disseminated BCG disease, so exclude SCID first where screening exists.
  • Any blood transfusion is safe in SCID: unirradiated blood carries lymphocytes that can cause fatal transfusion-associated GVHD.
  • Gene therapy carries the same GVHD risk as donor transplant: it uses the patient's own corrected cells, so there is no GVHD.

Test yourself

Think of the answer, then tap the question to see it.

What does a very low TREC level in a newborn screening sample suggest, and what should happen next?

Few new T cells from the thymus, as in SCID; confirm with lymphocyte flow cytometry, start protection and plan early transplant.

Why must blood products for SCID patients be irradiated?

To kill donor lymphocytes that could otherwise engraft and cause transfusion-associated graft-versus-host disease.

Why does IgG replacement work well in X-linked agammaglobulinaemia but not cure SCID?

XLA lacks only antibody, which can be replaced; SCID lacks T cells, which only a transplant or gene therapy can rebuild.

Why is a transplant preferably done in the first months of life in SCID?

Outcomes are best before serious infections take hold; each infection raises transplant risk.

Add to my cards (4)

Connections

← All of immunology

Educational content on the immune system; not a treatment or individual vaccination guide and no substitute for a health professional's advice. No doses are given.

Sources: X-linked severe combined immunodeficiency (MedlinePlus Genetics, US National Library of Medicine, 2024); Adenosine deaminase deficiency (MedlinePlus Genetics, US National Library of Medicine, 2024); Immunodeficiency diseases (MedlinePlus, US National Library of Medicine, 2024).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.